Prognostic significance of adenocarcinoma histology in women with cervical cancer.
about
Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervixLocally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiationAssessment of Cervical Cancer with a Parameter-Free Intravoxel Incoherent Motion Imaging AlgorithmHypoxia and TGF-β1 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formationLncRNA-TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR-143-5pTP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancerFoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinomaPrecise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers.Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma.LTPB2 acts as a prognostic factor and promotes progression of cervical adenocarcinoma[Prognostic factors of disease-free survival in patients with uterine cervix tumor].Nomogram prediction for overall survival of patients diagnosed with cervical cancer.HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer.Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer.Natural history and outcome of neuroendocrine carcinoma of the cervix.Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.Clear cell carcinoma of the uterine cervix: clinical characteristics and feasibility of fertility-preserving treatment.Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinomaOncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.Adenocarcinoma of the uterine cervix: why is it different?Adenocarcinoma of the cervix: should we treat it differently?Pattern classification of endocervical adenocarcinoma: reproducibility and review of criteria.Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management.Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.Cancer statistics for Hispanics/Latinos, 2015.Prognostic factors affecting cervical adenocarcinoma: 10 years experience in a single institution.The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.1 H MR spectroscopy in cervical carcinoma using external phase array body coil at 3.0 Tesla: Prediction of poor prognostic human papillomavirus genotypes.Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.Racial disparities in cervical cancer: Worse than we thought.Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.Tumor-associated CD204+ M2 macrophages is an unfavorable prognosticator in uterine cervical adenocarcinoma.The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
P2860
Q24201754-7BC6576A-6DD7-4129-9C4E-D41A5500BA0BQ30370106-F40D8EB8-0774-4518-996D-B62D4CDE101BQ33561409-856D272E-E5BA-4290-9D55-D964ACCADF3CQ33667630-51D9DBC4-80F2-4AE8-984F-DDA88521AC5AQ33775216-3AA9436F-2FFE-4960-98C3-EE901ADF6FAAQ34239911-1B57D6F1-27A9-4BD9-8D62-6697C8CDB24FQ34415906-C094FA6A-D0AF-47A5-8CC7-247BCDDE3BBEQ35687003-ADB6EEBE-7525-4944-962D-6404F982CB7BQ35702897-29A0D6BB-7B07-45C7-BDD0-7036C41DBA5FQ35741587-14401365-91A3-47DD-9426-A78A1F615B9DQ35867484-EC3DFCAA-AE8F-4A4D-B8B4-FC6D9448323BQ35941311-2E05CA8D-B749-4256-AC97-198246442525Q36250262-408A1606-4BB5-4BA9-86D8-D7B2B9E89AF1Q36299080-6445385B-2D0D-42C1-B4BA-73015F4F4F2DQ36346449-216BE540-9F8E-46C5-A6EF-9A7EE80B5C5DQ36482466-D1E5326C-E6C8-4819-945A-21B869EB1782Q36664130-676A1C46-5884-487E-80C8-C7B6624E6771Q36834895-802D4718-4403-4391-83F2-A0DEA73E5B28Q37036792-6A3EB94C-9785-40BB-9F42-2D7FFEACA4EEQ37477976-B7545524-0154-4530-86D9-22D611F7919AQ37569069-2AB17D0C-6427-4A35-ADEA-AD46EAF6C91FQ37662469-6045E307-C6A4-45E4-8059-55C0B4380816Q37678092-D1603E49-E170-4971-A229-10D34375E591Q38261137-C25039E2-AD11-4274-A322-B5ABF472FB8CQ38364617-7792B7CF-E09C-4E81-9244-4B111C1AAB9AQ38851794-F351C700-8311-4195-8874-EEC7DD208AF0Q38881050-065F68E8-C671-4C1E-90A2-5A228CC77CC0Q38894213-36A21DB9-C088-4490-94ED-B5499CE57C27Q38963293-57A5F754-51F3-47A0-9E80-F2EFA33F0457Q39131687-504FE320-8E68-4D3A-9901-DDAEC50967DCQ40115428-23CCDA6C-A574-41C8-BC9A-DCCF2D670824Q40607989-04E20B6F-37FC-4269-B25C-3AC7450F61FFQ42597487-CEC1D6CD-CFCC-48DC-8918-0BBF1F9A8A05Q45930451-1D8CFE7B-C567-44A3-9417-C636A4C994C0Q46457082-B85D45FC-219D-4A5E-BC96-3B5217F2DD13Q46562864-7E153D3A-3D75-4D6E-80C5-F4A1068E4437Q46666218-AF660D76-3743-44E9-94CA-7CF0DC16974DQ47560973-C5B49949-80A3-4F33-B5CD-4E93B69783F3Q47695956-0DD1F882-BE2B-4674-83A3-3D955AEA1943Q48312361-938D6438-192A-434B-B0A5-1667948C71B0
P2860
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
@en
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
@nl
type
label
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
@en
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
@nl
prefLabel
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
@en
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
@nl
P2093
P1433
P1476
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
@en
P2093
Alfred I Neugut
Jason D Wright
Sharyn N Lewin
Thomas J Herzog
Vijaya Galic
William M Burke
Yu-Shiang Lu
P304
P356
10.1016/J.YGYNO.2012.01.012
P407
P577
2012-01-18T00:00:00Z